Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Andreoli

Showing results (211-220 of 221) with videos related to

Pageof 23
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life SettingMariele Gatto, Francesca Saccon, Margherita Zen, et al.
Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.
Joint Bone Spine|December 24, 2018
"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseasesLaura Andreoli, Maria Grazia Lazzaroni, Chiara Carini, et al.
Clinical Reviews in Allergy & Immunology|March 16, 2021
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected IndividualsLaura Andreoli, Cecilia Nalli, Maria Grazia Lazzaroni, et al.
Autoimmunity Reviews|May 8, 2020
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, ItalyPaola Toniati, Simone Piva, Marco Cattalini, et al.
Rheumatology (Oxford, England)|July 28, 2023
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD studyLaura Andreoli, Daniele Lini, Karen Schreiber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Autoimmunity Reviews|October 15, 2018
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndromeCristina Belizna, Francesca Pregnolato, Sebastien Abad, et al.
The Lancet. Rheumatology|January 22, 2024
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseasesKaren Schreiber, Ian Giles, Nathalie Costedoat-Chalumeau, et al.
Pageof 23

Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life SettingMariele Gatto, Francesca Saccon, Margherita Zen, et al.
Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.
Joint Bone Spine|December 24, 2018
"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseasesLaura Andreoli, Maria Grazia Lazzaroni, Chiara Carini, et al.
Clinical Reviews in Allergy & Immunology|March 16, 2021
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected IndividualsLaura Andreoli, Cecilia Nalli, Maria Grazia Lazzaroni, et al.
Autoimmunity Reviews|May 8, 2020
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, ItalyPaola Toniati, Simone Piva, Marco Cattalini, et al.
Rheumatology (Oxford, England)|July 28, 2023
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD studyLaura Andreoli, Daniele Lini, Karen Schreiber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Autoimmunity Reviews|October 15, 2018
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndromeCristina Belizna, Francesca Pregnolato, Sebastien Abad, et al.
The Lancet. Rheumatology|January 22, 2024
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseasesKaren Schreiber, Ian Giles, Nathalie Costedoat-Chalumeau, et al.
Pageof 23